LENZ Therapeutics cuts costs, changes CEO as VIZZ sales rise 50%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. GOOGL
3. MSFT
4. ENPH
5. GOOG
6. HOOD
7. SPY
8. BA
9. NXPI
10. STX

Go back to LENZ Therapeutics cuts costs, changes CEO as VIZZ sales rise 50%

LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession

October 28, 2026 4:30 PM EDT

Q3 2026 VIZZ® product sales increased 50% over prior quarter, with strong momentum continuing into Q4 as consumer awareness broadens and telehealth adoption increases 

Strategic reorganization to prioritize consumer marketing, support the continued market expansion of VIZZ and reduce projected 2027 annual operating expenses by over 50%

Eef Schimmelpennink to transition from his role as President and Chief Executive Officer effective December 1, 2026; Dan Chevallard appointed Interim President and Chief Executive Officer

Management to host conference call on October 29, 2026, at 8:30 a.m. EDT

SAN DIEGO, Oct. 28,... More